Thermo Fisher (TMO) and Waters (WAT) on Torvanta's measures: TMO grades higher on 2 of the 4 factor families and WAT on 0.
| TMO | WAT | |
|---|---|---|
| Value grade | D+ | D |
| Growth grade | B- | B- |
| Profitability grade | C | D+ |
| Momentum grade | B+ | B+ |
| Market value | $255.1B | $42.9B |
| P/E (trailing) | 37.1x | 69.7x |
| Forward P/E (Torvanta model estimate) | Subscribers | Subscribers |
| Revenue, last 12 months | $46.3B | $4.6B |
| Revenue growth (y/y) | +7% | +55% |
| Operating margin | 17.6% | 7.1% |
| Return on invested capital | 8.0% | 1.4% |
| Free-cash-flow yield | 2.9% | 1.3% |
| Total return, 1 year | +29.0% | +30.5% |
| Total return, 3 years | +42.6% | +71.2% |
Full TMO analysis · Full WAT analysis
Thermo Fisher (TMO) and Waters (WAT) on Torvanta's measures: TMO grades higher on 2 of the 4 factor families and WAT on 0. Which fits an investor depends on their goals; this is research, not a recommendation. Subscribers see where the model ranks each and its expected return.
On trailing earnings TMO trades at 37.1x and WAT at 69.7x; their value grades are D+ and D against their sectors.
Subscribers get a rating, a fair value estimate, a 12-month target and a risk read for every S&P 500 company, Torvanta's earnings estimates, and three model portfolios (Active, Adaptive and Patient) with every trade sized and explained. A free account includes 3 full Stock Analyst reports a month.
See plans Or get the free weekly newsletterTorvanta is research only - not investment advice and not a recommendation to buy or sell any security. Grades describe a company's reported data against its sector; they are not the model's view, change as data changes and can be wrong. Financial figures come from the company's SEC filings; returns include reinvested dividends. Past performance does not predict future results.
All stock ratings · Stock lists · AI stock research · Model portfolio · Research · Disclaimer